Peripheral arterial disease, acute coronary syndromes, and early invasive management: The TACTICS TIMI 18 trial

Clinical Cardiology

Volumn 28, Issue 5, 2005, Pages 238-242

  Januzzi Jr , James L ^a   Buros, Jacqueline ^b   Cannon, Christopher P ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute coronary syndromes; Glycoprotein IIb IIIa receptor antagonists; Outcomes; Peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

ADULT; AGED; ANGIOGRAPHY; ARTERY DISEASE; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ECG ABNORMALITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; ST SEGMENT DEPRESSION; TREATMENT OUTCOME;

EID: 18744385826     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960280508     Document Type: Article

References (22)

1. Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, Milo O, Bentley J, Blatt A, Krakover R, Zimlichman R, Reisin L, Marmor A, Lewis B, Vered Z, Caspi A, Braunwald E: Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J 2003;145:622-627
2. Willens HJ, Davis W, Herrington DM, Wade K, Kesler K, Mallon S, Brown WV, Reiber JH, Raines JK: Relationship of peripheral arterial compliance and standard cardiovascular risk factors. Vasc Endovascular Surg 2003;37:197-206
3. Duffin DC, Muhlestein JB, Allisson SB, Home BD, Fowles RE, Sorensen SG, Revenaugh JR, Bair TL, Lappe DL: Femoral arterial puncture management after percutaneous coronary procedures: A comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invas Cardiol 2001;13:354-362
4. Hildick-Smith DJ, Walsh JT, Lowe MD, Stone DL, Schofield PM, Shapiro LM, Petch MC: Coronary angiography in the presence of peripheral vascular disease: Femoral or brachial/radial approach? Cathet Cardiovasc Interv 2000;49:32-37
5. Kohlman-Trigoboff D, Gongora E, Stanford J, Smith BM: Risk factors associated with acute lower extremity ischemia after coronary revascularization. J Vasc Nurs 2002;20:78-83
6. Nasser TK, Mohler ER III, Wilensky RL, Hathaway DR: Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 1995;18:609-614
7. Schweizer J, Kirch W, Koch R, Muller A, Hellner G, Forkmann L: Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis. Angiology 2003;54:155-161
8. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887
9. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. J Am Med Assoc 2000;284:835-842
10. Januzzi JL Jr, Sabatine MS, Wan Y, Servoss SJ, DiBattiste PM, Jang IK, Théroux P: Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy. Am J Cardiol 2003;91:457-461
11. Servoss SJ, Wan Y, Snapinn SM, DiBattiste PM, Zhao XQ, Théroux P, Jang IK, Januzzi JL Jr: Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial. Am J Cardiol 2004;93:843-847
12. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW, Moliterno DJ, Califf RM, White HD, Kleiman NS, Théroux P, Topol EJ: Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001;104:2767-2771
13. Kaul P, Fu Y, Chang WC, Harrington RA, Wagner GS, Goodman SG, Granger CB, Moliterno DJ, Van de Werf F, Califf RM, Topol EJ, Armstrong PW: Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol 2001;38:64-71
14. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C, Hamm CW, Robbins MA, Kleiman NS, Théroux P, White HD, Topol FJ: Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J 2002;23:1441-1448
15. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRE). Lancet 1996;348:1329-1339
16. Buchholz AM, Bruch L, Schulte KL: Activation of circulating platelets in patients with peripheral arterial disease during digital subtraction angiography and percutaneous transluminal angioplasty. Thromb Res 2003;109:13-22
17. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J: Platelet activation is increased in peripheral arterial disease. J Vasc Surg 2003;38:99-103
18. Robless PA, Okonko D, Lintott P, Mansfield AO, Mikhailidis DP, Stansby GP: Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 2003;25:16-22
19. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV: Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004;109:733-739
20. Heidrich H, Wenk R, Hesse P: Frequency of asymptomatic peripheral arterial disease in patients entering the department of general and internal medicine of a general-care hospital. Vasa 2004;33:63-67
21. Breveta G, Oliva G, Silvestro A, Scopacasa F, Chiariello M: Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004;175:131-138
22. Dieter RS, Tomasson J, Gudjonsson T, Brown RL, Vitcenda M, Einerson J, McBride PE: Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease. Vasc Med 2003;8:233-236